Altre lingue Venus Remedies Limited

Azioni

VENUSREM

INE411B01019

Tempo differito Bombay S.E. Altri mercati azionari 07:30:26 28/06/2024			Variaz. 5gg	Var. 1 gen.
359,2 ^INR	+3,14%		-5,02%	-11,50%

13/06	Venus Remedies ottiene una gara d'appalto dall'UNICEF per l'antibiotico Ceftriaxone	MT
30/05	Venus Remedies Limited riporta i risultati degli utili per il quarto trimestre e l'intero anno terminato il 31 marzo 2024	CI

Altre lingue

Sblocca tutte le notizie su tutte le aziende: non perdere mai più un'opportunità di investimento redditizia!

Registrazione 100% gratuita

Venus Remedies Bags Tender from UNICEF for Antibiotic Ceftriaxone	13/06
Venus Remedies Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2024	30/05
Venus Remedies Secures Marketing Authorizations in Ukraine for Three Oncology Drugs	19/03
Venus Remedies Gets Ukraine's Marketing Approval for Three Oncology Products	08/03
Venus Remedies Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	14/02
Venus Remedies Gets Ukraine Marketing Approval for Chemotherapy Drug, Antibiotics	13/02
Venus Remedies Gets Marketing Authorization in Malta for Two Chemotherapy Drugs	12/01
Venus Remedies Gets Authorization to Market Cancer Drugs in Israel, Colombia	21/12
Indian Equities Clock Sharp Losses on Wednesday Due to Widespread Selling	20/12
Venus Remedies Expands Into Wellness Business	20/12
Venus Remedies Gets Bahrain Marketing Authorization for Enoxaparin	19/12
Indian Equities Score Another Record Highs on Tuesday, Lifted by Ruling Party's State Polls Win	05/12
Venus Remedies Gets Azerbaijan's Marketing Approval for Blood Clot Prevention Drug	05/12
Venus Remedies Gets Marketing Approval for Cancer Drugs in Philippines, Saudi Arabia	01/12
Venus Remedies Limited Receives Market Authorizations in Saudi Arabia and Philippines	01/12
Venus Remedies' Consolidated Profit Jumps in Fiscal Q2	27/11
Venus Remedies Arm Gets Authorization to Market Cancer Drug in UK	26/10/23
Venus Remedies Secures Marketing Approval for Six Key Chemotherapy Drugs in Philippines	16/10/23
Venus Remedies Limited Receives Marketing Approval from the Philippines for Six Key Chemotherapy Drugs	16/10/23
Venus Remedies Launches Antibiotic Elores in Ecuador	12/10/23

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue Venus Remedies Limited

Azioni

VENUSREM

INE411B01019

Altre lingue

Filtri